354 related articles for article (PubMed ID: 23871581)
1. An experience with plasma exchange treatment of acute lymphoblastic leukemia in a case with fulminant hepatitis related to L-asparaginase.
Bilgir O; Calan M; Bilgir F; Cagliyan G; Arslan O
Transfus Apher Sci; 2013 Oct; 49(2):328-30. PubMed ID: 23871581
[TBL] [Abstract][Full Text] [Related]
2. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
Tsutsui M; Koike M; Komatsu N
Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
[TBL] [Abstract][Full Text] [Related]
3. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
Bodmer M; Sulz M; Stadlmann S; Droll A; Terracciano L; Krähenbühl S
Digestion; 2006; 74(1):28-32. PubMed ID: 16988508
[TBL] [Abstract][Full Text] [Related]
4. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
6. Histopathological features of L-asparaginase-induced liver disease.
Sahoo S; Hart J
Semin Liver Dis; 2003 Aug; 23(3):295-9. PubMed ID: 14523682
[TBL] [Abstract][Full Text] [Related]
7. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.
Hijiya N; van der Sluis IM
Leuk Lymphoma; 2016; 57(4):748-57. PubMed ID: 26457414
[TBL] [Abstract][Full Text] [Related]
8. [New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase].
Sikorska-Fic B; Makowska K; Rokicka-Milewska R
Wiad Lek; 1998; 51 Suppl 4():233-6. PubMed ID: 10731974
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
Larson RA; Fretzin MH; Dodge RK; Schiffer CA
Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors.
Al-Nawakil C; Willems L; Mauprivez C; Laffy B; Benm'rad M; Tamburini J; Fontaine H; Sogni P; Terris B; Bouscary D; Moachon L
Leuk Lymphoma; 2014 Jul; 55(7):1670-4. PubMed ID: 24090500
[No Abstract] [Full Text] [Related]
11. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
12. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia.
Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528
[TBL] [Abstract][Full Text] [Related]
13. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
Earl M
Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
[TBL] [Abstract][Full Text] [Related]
14. [Distal coronary thrombosis during L-asparaginase treatment for an acute lymphoblastic leukaemia].
Fraison JB; Calvet P; Domnisoru I; Altamiranda S; Vernhet-Kovacsik H; Saad A; Gallay P; Reny JL; Berdague P
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):303-5. PubMed ID: 21663890
[TBL] [Abstract][Full Text] [Related]
15. Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
Bade NA; Lu C; Patzke CL; Baer MR; Duong VH; Law JY; Lee ST; Sausville EA; Zimrin AB; Duffy AP; Lawson J; Emadi A
J Oncol Pharm Pract; 2020 Jan; 26(1):74-92. PubMed ID: 30917738
[TBL] [Abstract][Full Text] [Related]
16. L-asparaginase induced acute parotitis during intensification therapy of acute lymphoblastic leukemia.
Kathwate J; Mundada S; Patil P
Indian J Cancer; 2014; 51(4):537. PubMed ID: 26842187
[No Abstract] [Full Text] [Related]
17. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
[TBL] [Abstract][Full Text] [Related]
18. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
[TBL] [Abstract][Full Text] [Related]
19. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
[TBL] [Abstract][Full Text] [Related]
20. Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia.
Burke MJ; Rheingold SR
Leuk Lymphoma; 2017 Mar; 58(3):540-551. PubMed ID: 27546298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
